Citadel Advisors’s QIAGEN NV QGENF Stock Holding History

Citadel Advisors’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,900	Closed	-$49K	–	9842
2015 Q3	$49K	Sell	1,900 -4,700	-71%	-$121K	﹤0.01%	7604
2015 Q2	$164K	Buy	+6,600	New	+$164K	﹤0.01%	6566
2014 Q3	–	Sell	-2,300	Closed	-$56K	–	8878
2014 Q2	$56K	Buy	2,300 +2,100	+1,050%	+$51.1K	﹤0.01%	6686
2014 Q1	$4K	Sell	200 -1,400	-88%	-$28K	﹤0.01%	7693
2013 Q4	$38K	Buy	+1,600	New	+$38K	﹤0.01%	6189

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Citadel Advisors's QGENF Position: Q1 2017 in Review

Citadel Advisors sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 619,249 shares — an estimated $17.4M sold.

Citadel Advisors first reported a position in QGENF in Q4 2013 and held it in 8 quarters. The position peaked at $28.1M in Q2 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

Citadel Advisors reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
Citadel Advisors sold 619,249 QIAGEN NV shares in Q1 2017, an estimated $17.4M.
Citadel Advisors first reported a position in QIAGEN NV in Q4 2013 and held it in 8 quarters.
Citadel Advisors's QIAGEN NV position peaked at $28.1M in Q2 2016.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.